Basic fibroblast growth factor does not prolong survival in a transgenic model of familial amyotrophic lateral sclerosis

Ann Neurol. 1999 Dec;46(6):934. doi: 10.1002/1531-8249(199912)46:6<934::aid-ana21>3.0.co;2-0.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Fibroblast Growth Factor 2 / administration & dosage
  • Fibroblast Growth Factor 2 / therapeutic use*
  • Humans
  • Injections, Intraperitoneal
  • Mice
  • Mice, Transgenic
  • Motor Neuron Disease / drug therapy*
  • Motor Neuron Disease / genetics
  • Motor Neuron Disease / physiopathology
  • Superoxide Dismutase / genetics*

Substances

  • Fibroblast Growth Factor 2
  • Superoxide Dismutase